Legis Daily

Accelerated Approval Transparency Act

USA117th CongressS-4390| Senate 
| Updated: 6/14/2022
John W. Hickenlooper

John W. Hickenlooper

Democratic Senator

Colorado

Health, Education, Labor, and Pensions Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Accelerated Approval Transparency Act This bill requires the Food and Drug Administration to include a summary of the reasons a drug or biologic received accelerated approval to treat a serious or life-threatening disease or condition in the public action package for the drug or biologic.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jun 14, 2022
Introduced in Senate
Jun 14, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • June 14, 2022
    Introduced in Senate


  • June 14, 2022
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Health

Accelerated Approval Transparency Act

USA117th CongressS-4390| Senate 
| Updated: 6/14/2022
Accelerated Approval Transparency Act This bill requires the Food and Drug Administration to include a summary of the reasons a drug or biologic received accelerated approval to treat a serious or life-threatening disease or condition in the public action package for the drug or biologic.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jun 14, 2022
Introduced in Senate
Jun 14, 2022
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
  • June 14, 2022
    Introduced in Senate


  • June 14, 2022
    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
John W. Hickenlooper

John W. Hickenlooper

Democratic Senator

Colorado

Health, Education, Labor, and Pensions Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted